Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion Drugs
127 results

Sort 127 results by:

Filter Applied. Clear All
Reset All Filters
A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification.
Abortion Drugs

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala, Ph.D. Ingrid Skop, M.D., FACOG
October 6, 2026
Please login to bookmark Close
Ultrasound image showing the side profile of a human baby
Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined.
Abortion Drugs

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Graphic featuring a series of black horizontal brushstrokes leading into a circular geometric pattern, followed by the letters FDA in a stylized font, set against a white crinkled paper background for a peer-reviewed article on the abortion drug.
Abortion Drugs

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

CLI logo
Abortion Drugs

Peer-Reviewed Research on Online Narratives About Abortion Drugs

CLI Associate Scholar Katherine Rafferty, Ph.D., discussed her research on online narratives about abortion drugs post-Dobbs in a webinar.

A person with pink nail polish holds a glass of water in one hand and a white pill in the other, their head bowed down, partially obscured by their hair—a quiet moment that reflects many women’s experiences as shared through online narratives about medication abortion.
Abortion Drugs

Examining women’s experiences with medication abortion: a critical inquiry of women’s online narratives post-Dobbs

This new peer-reviewed study from CLI scholars examined the experiences of women who had a medication abortion and chose to…

A hand in a blue glove holds a box labeled Mifepristone Tablets with a barcode and description stating its use for pregnancy termination and medical abortion, while recent controversies have brought increased attention to both Mifepristone and its uses beyond abortion.
Abortion Drugs

Uses for Mifepristone Beyond Abortion: Addressing Recent Controversies

Some have raised concerns that limitations on mifepristone will harm women who need access to the drug for non-abortion indications.…

A $100 U.S. bill, featuring Benjamin Franklin's portrait, is shown in red and black tones, with all text and details visible—including denomination and serial numbers—hinting at issues like State Funding or Federal Defunding of programs such as Planned Parenthood.
Abortion Drugs

Fact Sheet: State Funding of Planned Parenthood in Response to Federal Defunding

The 2025 Federal Budget Reconciliation Act imposed a one-year prohibition on Medicaid reimbursements to certain organizations that provide abortion services.…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image